<code id='BFF2260F37'></code><style id='BFF2260F37'></style>
    • <acronym id='BFF2260F37'></acronym>
      <center id='BFF2260F37'><center id='BFF2260F37'><tfoot id='BFF2260F37'></tfoot></center><abbr id='BFF2260F37'><dir id='BFF2260F37'><tfoot id='BFF2260F37'></tfoot><noframes id='BFF2260F37'>

    • <optgroup id='BFF2260F37'><strike id='BFF2260F37'><sup id='BFF2260F37'></sup></strike><code id='BFF2260F37'></code></optgroup>
        1. <b id='BFF2260F37'><label id='BFF2260F37'><select id='BFF2260F37'><dt id='BFF2260F37'><span id='BFF2260F37'></span></dt></select></label></b><u id='BFF2260F37'></u>
          <i id='BFF2260F37'><strike id='BFF2260F37'><tt id='BFF2260F37'><pre id='BFF2260F37'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:3341

          Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

          advertisement

          For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          explore

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          With clinical trial data readouts, here's how to spot spin
          With clinical trial data readouts, here's how to spot spin

          AdobeInvestors,analysts,doctors,andevenpatientsfaceanavalancheofnewsfrombiotechcompaniesabouttheirhu

          read more
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more

          Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

          Hevolution'sexecutiveteamincludes,fromleft,SophiaPathai,HayaBintKhaledBinBandarAlSaud,MehmoodKhan,an